{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:30:00Z","timestamp":1793179800868,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270203"],"award-info":[{"award-number":["82270203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.rpth.2024.102552","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T10:24:06Z","timestamp":1724408646000},"page":"102552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4690-4040","authenticated-orcid":false,"given":"Kefeng","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9421-6344","authenticated-orcid":false,"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102552_bib1","first-page":"288","article-title":"Thrombocytopenia: evaluation and management","volume":"106","author":"Gauer","year":"2022","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.rpth.2024.102552_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.12703\/P6-45","article-title":"Management of thrombocytopenia","volume":"6","author":"Izak","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.rpth.2024.102552_bib3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102552_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/asheducation-2018.1.576","article-title":"Drug-associated thrombocytopenia","volume":"2018","author":"Bakchoul","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2024.102552_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/17474086.2017.1271319","article-title":"Thrombocytopenia and infections","volume":"10","author":"Franchini","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.rpth.2024.102552_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMra2214617","article-title":"Management of primary immune thrombocytopenia in pregnancy","volume":"389","author":"Bussel","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102552_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101112","article-title":"Primary and secondary immune thrombocytopenia (ITP): time for a rethink","volume":"61","author":"Gonz\u00e1lez-L\u00f3pez","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2024.102552_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100784","article-title":"Inherited thrombocytopenias: an updated guide for clinicians","volume":"48","author":"Pecci","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2024.102552_bib9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood.2019003599","article-title":"Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment","volume":"135","author":"Miltiadous","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/jth.12196","article-title":"Inherited thrombocytopenias frequently diagnosed in adults","volume":"11","author":"Balduini","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102552_bib11","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3324\/haematol.2019.233197","article-title":"Inherited thrombocytopenias: history, advances and perspectives","volume":"105","author":"Nurden","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102552_bib12","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1182\/blood.2020009300","article-title":"Genetics of inherited thrombocytopenias","volume":"139","author":"Warren","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.2011.08716.x","article-title":"Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias","volume":"154","author":"Balduini","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102552_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/01.md.0000076006.64510.5c","article-title":"MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness","volume":"82","author":"Seri","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rpth.2024.102552_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1220327","article-title":"MYH9-related platelet disorders","volume":"35","author":"Althaus","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102552_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9343(72)90017-4","article-title":"Hereditary macrothrombocytopathia, nephritis and deafness","volume":"52","author":"Epstein","year":"1972","journal-title":"Am J Med"},{"key":"10.1016\/j.rpth.2024.102552_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood.V65.2.397.397","article-title":"Fechtner syndrome--a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia","volume":"65","author":"Peterson","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF01732878","article-title":"Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusions","volume":"61","author":"Greinacher","year":"1990","journal-title":"Blut"},{"key":"10.1016\/j.rpth.2024.102552_bib19","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nrm2786","article-title":"Non-muscle myosin II takes centre stage in cell adhesion and migration","volume":"10","author":"Vicente-Manzanares","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.rpth.2024.102552_bib20","first-page":"1495","article-title":"Non-muscle myosin II in disease: mechanisms and therapeutic opportunities","volume":"8","author":"Newell-Litwa","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.rpth.2024.102552_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.gene.2018.04.048","article-title":"MYH9: structure, functions and role of non-muscle myosin IIA in human disease","volume":"664","author":"Pecci","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.rpth.2024.102552_bib22","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/cells9061458","article-title":"Linking the landscape of MYH9-related diseases to the molecular mechanisms that control non-muscle myosin II-A function in cells","volume":"9","author":"Asensio-Ju\u00e1rez","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.rpth.2024.102552_bib23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0002-9297(07)62942-5","article-title":"Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9","volume":"67","author":"Lalwani","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rpth.2024.102552_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/ckj\/sfz103","article-title":"MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy","volume":"12","author":"Fernandez-Prado","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.rpth.2024.102552_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/humu.23927","article-title":"Next-generation sequencing for the diagnosis of MYH9-RD: predicting pathogenic variants","volume":"41","author":"Bury","year":"2020","journal-title":"Hum Mutat"},{"key":"10.1016\/j.rpth.2024.102552_bib26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/humu.22476","article-title":"MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations","volume":"35","author":"Pecci","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1016\/j.rpth.2024.102552_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10157-023-02404-3","article-title":"A\u00a0nationwide survey of MYH9-related disease in Japan","volume":"28","author":"Shirai","year":"2024","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.rpth.2024.102552_bib28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0609.2009.01274.x","article-title":"Identification of three in-frame deletion mutations in MYH9 disorders suggesting an important hot spot for small rearrangements in MYH9 exon 24","volume":"83","author":"Miyazaki","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.rpth.2024.102552_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/humu.20661","article-title":"Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease","volume":"29","author":"Pecci","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.rpth.2024.102552_bib30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/bjh.12797","article-title":"Somatic mosaicism in MYH9 disorders: the need to carefully evaluate apparently healthy parents","volume":"165","author":"Kunishima","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102552_bib31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2141.2005.05658.x","article-title":"Genotype-phenotype correlation in MYH9-related thrombocytopenia","volume":"130","author":"Dong","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102552_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ki.2010.21","article-title":"Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease","volume":"78","author":"Sekine","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.rpth.2024.102552_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jfma.2012.07.024","article-title":"R1933X mutation in the MYH9 gene in May-Hegglin anomaly mimicking idiopathic thrombocytopenic purpura","volume":"113","author":"Sung","year":"2014","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.rpth.2024.102552_bib34","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1242\/jcs.094300","article-title":"The myosin superfamily at a glance","volume":"125","author":"Hartman","year":"2012","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.rpth.2024.102552_bib35","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.tibs.2016.09.006","article-title":"How myosin generates force on actin filaments","volume":"41","author":"Houdusse","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.rpth.2024.102552_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.devcel.2015.03.025","article-title":"How actin initiates the motor activity of myosin","volume":"33","author":"Llinas","year":"2015","journal-title":"Dev Cell"},{"key":"10.1016\/j.rpth.2024.102552_bib37","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1538-7836.2008.03132.x","article-title":"Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes","volume":"6","author":"Balduini","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102552_bib38","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood-2013-06-508168","article-title":"Myosin IIA is critical for organelle distribution and F-actin organization in megakaryocytes and platelets","volume":"123","author":"Pertuy","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib39","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1182\/blood-2014-06-584995","article-title":"Carboxyl-terminal-dependent recruitment of nonmuscle myosin II to megakaryocyte contractile ring during polyploidization","volume":"124","author":"Badirou","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib40","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1182\/blood-2016-04-711630","article-title":"Activity of nonmuscle myosin II isoforms determines localization at the cleavage furrow of megakaryocytes","volume":"128","author":"Roy","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib41","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2215\/CJN.08721209","article-title":"The spectrum of MYH9-associated nephropathy","volume":"5","author":"Bostrom","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.rpth.2024.102552_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semnephrol.2010.01.003","article-title":"Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: the role of MYH9 genetic variation","volume":"30","author":"Winkler","year":"2010","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.rpth.2024.102552_bib43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cm.21313","article-title":"Non-muscle myosin-IIA is critical for podocyte f-actin organization, contractility, and attenuation of cell motility","volume":"73","author":"Bondzie","year":"2016","journal-title":"Cytoskeleton (Hoboken)"},{"key":"10.1016\/j.rpth.2024.102552_bib44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/jnr.20993","article-title":"Expression of Myh9 in the mammalian cochlea: localization within the stereocilia","volume":"84","author":"Mhatre","year":"2006","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.rpth.2024.102552_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2007.12.058","article-title":"Localization in stereocilia, plasma membrane, and mitochondria suggests diverse roles for NMHC-IIa within cochlear hair cells","volume":"1197","author":"Lalwani","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.rpth.2024.102552_bib46","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1160\/TH09-08-0593","article-title":"Heavy chain myosin 9-related disease (MYH9 -RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder","volume":"103","author":"Savoia","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102552_bib47","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13513","article-title":"Nonmuscle myosin 2 proteins encoded by Myh9, Myh10, and Myh14 are uniquely distributed in the tubular segments of murine kidney","volume":"5","author":"Otterpohl","year":"2017","journal-title":"Physiol Rep"},{"key":"10.1016\/j.rpth.2024.102552_bib48","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/j.1538-7836.2009.03614.x","article-title":"Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia","volume":"7","author":"Noris","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102552_bib49","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.thromres.2006.06.011","article-title":"Identification of inherited macrothrombocytopenias based on mean platelet volume among patients diagnosed with idiopathic thrombocytopenia","volume":"119","author":"Gohda","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2024.102552_bib50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/bjh.12349","article-title":"Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study","volume":"162","author":"Noris","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102552_bib51","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1182\/blood-2014-03-564328","article-title":"Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1751-553X.2007.00909.x","article-title":"Continuing developments with the automated platelet count","volume":"29","author":"Briggs","year":"2007","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.rpth.2024.102552_bib53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1309\/EK3C7CTDKNVPXVTN","article-title":"Automated blood cell counts: state of the art","volume":"130","author":"Buttarello","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.rpth.2024.102552_bib54","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/09537104.2017.1294250","article-title":"MYH9 gene mutations associated with bleeding","volume":"28","author":"Savoia","year":"2017","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2024.102552_bib55","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjh.13324","article-title":"MYH9-related thrombocytopenia and intracranial bleedings: a complex clinical\/surgical management and review of the literature","volume":"170","author":"Palandri","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102552_bib56","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1111\/hae.14147","article-title":"Obstetrical bleeding in women with MYH9-related disease-A systematic review","volume":"27","author":"Punt","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102552_bib57","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2007-03-080184","article-title":"Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion","volume":"110","author":"L\u00e9on","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib58","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1182\/bloodadvances.2022008011","article-title":"Defective VWF secretion due to expression of MYH9-RD E1841K mutant in endothelial cells disrupts hemostasis","volume":"6","author":"Cao","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2024.102552_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn2627","article-title":"Reduced platelet forces underlie impaired hemostasis in mouse models of MYH9-related disease","volume":"8","author":"Baumann","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.rpth.2024.102552_bib60","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/jth.13729","article-title":"Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders","volume":"15","author":"Greinacher","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102552_bib61","first-page":"539","article-title":"Diagnosis of inherited platelet disorders on a blood smear","volume":"9","author":"Zaninetti","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.rpth.2024.102552_bib62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.LAB.0000050960.48774.17","article-title":"Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations","volume":"83","author":"Kunishima","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.rpth.2024.102552_bib63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MOH.0b013e32833c069c","article-title":"Advances in the understanding of MYH9 disorders","volume":"17","author":"Kunishima","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2024.102552_bib64","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood.2021012044","article-title":"Microscope diagnosis of MYH9-related thrombocytopenia","volume":"138","author":"Sadaf","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib65","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3324\/haematol.2021.279022","article-title":"Images from the Haematologica Atlas of Hematologic Cytology: MYH9-related disease","volume":"106","author":"Balduini","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102552_bib66","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrneph.2012.42","article-title":"Proteinuria should be used as a surrogate in CKD","volume":"8","author":"Cravedi","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.rpth.2024.102552_bib67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/AUD.0000000000000198","article-title":"Nonmuscle myosin heavy chain IIA mutation predicts severity and progression of sensorineural hearing loss in patients with MYH9-related disease","volume":"37","author":"Verver","year":"2016","journal-title":"Ear Hear"},{"key":"10.1016\/j.rpth.2024.102552_bib68","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1097\/MAO.0000000000003450","article-title":"Characterization of sensorineural hearing loss in patients with MYH9-related disease: a systematic review","volume":"43","author":"Peddu","year":"2022","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.rpth.2024.102552_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035986","article-title":"Alteration of liver enzymes is a feature of the MYH9-related disease syndrome","volume":"7","author":"Pecci","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2024.102552_bib70","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000320335","article-title":"MYH-9 related platelet disorders: strategies for management and diagnosis","volume":"37","author":"Althaus","year":"2010","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.rpth.2024.102552_bib71","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3324\/haematol.2016.146316","article-title":"Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects","volume":"101","author":"Johnson","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102552_bib72","doi-asserted-by":"crossref","first-page":"94S","DOI":"10.1177\/1076029618790696","article-title":"Application of high-throughput sequencing in the diagnosis of inherited thrombocytopenia","volume":"24","author":"Wang","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102552_bib73","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1055\/s-0038-1676813","article-title":"Use of targeted high-throughput sequencing for genetic classification of patients with bleeding diathesis and suspected platelet disorder","volume":"2","author":"Andres","year":"2018","journal-title":"TH Open"},{"key":"10.1016\/j.rpth.2024.102552_bib74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2156-14-6","article-title":"Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations","volume":"14","author":"Chin","year":"2013","journal-title":"BMC Genet"},{"key":"10.1016\/j.rpth.2024.102552_bib75","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0032-1333540","article-title":"Diagnosis and management of inherited thrombocytopenias","volume":"39","author":"Balduini","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102552_bib76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cge.12603","article-title":"Diagnosis and treatment of inherited thrombocytopenias","volume":"89","author":"Pecci","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.rpth.2024.102552_bib77","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2022.280856","article-title":"Treatment of inherited thrombocytopenias","volume":"107","author":"Balduini","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102552_bib78","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/bjh.14520","article-title":"The aspirin story - from willow to wonder drug","volume":"177","author":"Desborough","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102552_bib79","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1055\/s-0032-1328881","article-title":"Drugs that affect platelet function","volume":"38","author":"Scharf","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2024.102552_bib80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/asheducation-2009.1.267","article-title":"Antiplatelet agents","author":"Varon","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2024.102552_bib81","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1111\/jth.15102","article-title":"\"Everything was blood when it comes to me\": understanding the lived experiences of women with inherited bleeding disorders","volume":"18","author":"Arya","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102552_bib82","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3324\/haematol.2014.105924","article-title":"Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia","volume":"99","author":"Noris","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102552_bib83","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/hae.14221","article-title":"Managing women-specific bleeding in inherited bleeding disorders: a multidisciplinary approach","volume":"27","author":"Mauser-Bunschoten","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102552_bib84","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1182\/blood.2023020726","article-title":"How I treat thrombocytopenia in pregnancy","volume":"143","author":"Fogerty","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib85","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpag.2009.11.008","article-title":"Menorrhagia in adolescents with inherited bleeding disorders","volume":"23","author":"Chi","year":"2010","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.rpth.2024.102552_bib86","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3324\/haematol.2016.160754","article-title":"Bleeding risk of surgery and its prevention in patients with inherited platelet disorders","volume":"102","author":"Orsini","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102552_bib87","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.2022016558","article-title":"How I use platelet transfusions","volume":"140","author":"Stanworth","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib88","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102552_bib89","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1182\/hematology.2020000137","article-title":"Platelet transfusion refractoriness: how do I diagnose and manage?","volume":"2020","author":"Cohn","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rpth.2024.102552_bib90","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/hae.12254","article-title":"Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders","volume":"20","author":"Leissinger","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2024.102552_bib91","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ajh.20446","article-title":"Perioperative management of a patient with May-Hegglin anomaly requiring craniotomy","volume":"79","author":"Sehbai","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2024.102552_bib92","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/jth.14217","article-title":"Thrombopoietin receptor agonists in hereditary thrombocytopenias","volume":"16","author":"Rodeghiero","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102552_bib93","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1182\/blood-2010-08-304725","article-title":"Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations","volume":"116","author":"Pecci","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2024.102552_bib94","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1160\/TH12-01-0005","article-title":"Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation","volume":"107","author":"Pecci","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102552_bib95","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/09537104.2017.1356920","article-title":"Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia","volume":"29","author":"Rabbolini","year":"2018","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2024.102552_bib96","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3324\/haematol.2019.223966","article-title":"Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial","volume":"105","author":"Zaninetti","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2024.102552_bib97","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpneph0076","article-title":"Drug-associated renal dysfunction and injury","volume":"2","author":"Choudhury","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.rpth.2024.102552_bib98","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.2169\/internalmedicine.2997-19","article-title":"Renin-angiotensin system blockade therapy for early renal involvement in MYH9-related disease with an E1841K mutation","volume":"58","author":"Tanaka","year":"2019","journal-title":"Intern Med"},{"key":"10.1016\/j.rpth.2024.102552_bib99","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.12688\/f1000research.9215.1","article-title":"Recent advances in prenatal genetic screening and testing","volume":"5","author":"Van den Veyver","year":"2016","journal-title":"F1000Res"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924002474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924002474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T23:25:22Z","timestamp":1728602722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924002474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2475037924002474"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102552","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102552"}}